We report evidence that TSC and FCD IIb are characterized by OS, chronic Nrf‐2 activation and provide indications that redox state and iron metabolism are altered in both these developmental malformations related to mTOR dysregulation. The gene discussed is NFE2L2; the disease is tuberous sclerosis.